Literature DB >> 7950693

ABC of breast diseases. Breast cancer--epidemiology, risk factors and genetics.

K McPherson1, C M Steel, J M Dixon.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7950693      PMCID： PMC2541301          DOI： 10.1136/bmj.309.6960.1003

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

Review 1.  Diet and breast cancer.

Authors:  L J Kinlen
Journal:  Br Med Bull       Date:  1991-04       Impact factor: 4.291

2.  Contralateral primary tumors in breast cancer patients in a randomized trial of adjuvant tamoxifen therapy.

Authors:  L E Rutqvist; B Cedermark; U Glas; A Mattsson; L Skoog; A Somell; T Theve; N Wilking; J Askergren; M L Hjalmar
Journal:  J Natl Cancer Inst       Date:  1991-09-18       Impact factor: 13.506
  2 in total
  16 in total

1.  A model protocol evaluating the introduction of genetic assessment for women with a family history of breast cancer.

Authors:  J Gray; K Brain; P Norman; C Anglim; L France; G Barton; L Branston; E Parsons; A Clarke; J Sampson; E Roberts; R Newcombe; D Cohen; C Rogers; R Mansel; P Harper
Journal:  J Med Genet       Date:  2000-03       Impact factor: 6.318

2.  Risk factors for breast cancer. Pollutants and pesticides may be important.

Authors:  P J Lewis
Journal:  BMJ       Date:  1994-12-17

3.  Extending the benefits of breast cancer screening. Still hard to know how large the benefits will really be.

Authors:  U Werneke; K McPherson
Journal:  BMJ       Date:  1998-08-08

Review 4.  Breast cancer management: quality-of-life and cost considerations.

Authors:  Davide Radice; Alberto Redaelli
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

5.  Loss of heterozygosity and microsatellite instability in breast hyperplasia. No obligate correlation of these genetic alterations with subsequent malignancy.

Authors:  M Kasami; C L Vnencak-Jones; S Manning; W D Dupont; D L Page
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

6.  Attitudes towards cancer predictive testing and transmission of information to the family.

Authors:  C Julian-Reynier; F Eisinger; P Vennin; F Chabal; Y Aurran; C Noguès; Y J Bignon; M Machelard-Roumagnac; C Maugard-Louboutin; D Serin; B Blanc; P Orsoni; H Sobol
Journal:  J Med Genet       Date:  1996-09       Impact factor: 6.318

Review 7.  Epirubicin: a review of its efficacy as adjuvant therapy and in the treatment of metastatic disease in breast cancer.

Authors:  D Ormrod; K Holm; K Goa; C Spencer
Journal:  Drugs Aging       Date:  1999-11       Impact factor: 3.923

8.  A functional and regulatory network associated with PIP expression in human breast cancer.

Authors:  Marie-Anne Debily; Sandrine El Marhomy; Virginie Boulanger; Eric Eveno; Régine Mariage-Samson; Alessandra Camarca; Charles Auffray; Dominique Piatier-Tonneau; Sandrine Imbeaud
Journal:  PLoS One       Date:  2009-03-05       Impact factor: 3.240

9.  Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening. United Kingdom Association of Cancer Registries.

Authors:  M Quinn; E Allen
Journal:  BMJ       Date:  1995-11-25

Review 10.  Associations between physical activity and susceptibility to cancer: possible mechanisms.

Authors:  R J Shephard; P N Shek
Journal:  Sports Med       Date:  1998-11       Impact factor: 11.136
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.